Vibrotactile Stimulation for Spasmodic Dysphonia

(Neuro-VTS-LD Trial)

This trial explores how vibrotactile stimulation (VTS), a non-invasive treatment using gentle vibrations, might help people with laryngeal dystonia, a condition causing voice and speech problems due to muscle spasms. Researchers aim to understand how VTS improves voice quality, eases speaking, and what changes occur in the brain during treatment. Participants with laryngeal dystonia, diagnosed by a specialist and not regularly using certain medications, may qualify. Healthy individuals with no speech issues are also needed for comparison. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new treatment options.

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you regularly take benzodiazepines.

A previous study found that up to 57% of people with laryngeal dystonia noticed better voice quality after using vibrotactile stimulation (VTS). This non-invasive treatment does not involve surgery or cause pain. While it may produce a mild tingling sensation, most people find it comfortable. Research has also shown that VTS can ease speaking and enhance voice quality without significant side effects. This suggests that VTS is a safe option for managing symptoms of spasmodic dysphonia.¹²³⁴⁵

Researchers are excited about vibrotactile stimulation for spasmodic dysphonia because it offers a non-invasive approach that targets the condition differently from traditional treatments. Most current options, like botulinum toxin injections and voice therapy, focus on symptom management by relaxing muscles or retraining vocal techniques. In contrast, vibrotactile stimulation aims to modulate neural pathways involved in voice control through gentle vibrations, potentially offering a novel way to improve vocal function without the need for injections or intensive therapy sessions. This innovative method could lead to more accessible and less invasive treatment options for patients.

Research has shown that gentle vibrations on the throat, known as vibrotactile stimulation (VTS), can improve voice quality and ease speaking for people with laryngeal dystonia, also called spasmodic dysphonia. One study found that up to 57% of participants experienced significant voice improvements lasting from a few minutes to several days. Another study reported that 64% of participants noticed a clear improvement in voice quality. This trial will compare the effects of VTS on individuals with laryngeal dystonia to healthy controls. The treatment works by applying gentle vibrations to the throat, which seems to help control the muscle spasms causing speech problems. Although scientists continue to study its exact mechanism, VTS is appealing because it is non-invasive, requiring no surgery or other intrusive procedures.¹²³⁵⁶